Annual report pursuant to Section 13 and 15(d)

Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details)

v3.24.1
Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets:    
Net operating loss carryforwards $ 55,797 $ 53,842
Stock-based compensation 3,171 3,099
Federal R&D credit 2,222 2,222
Accrued expenses 121 101
Capitalized research expenses 3,083 1,448
Intangibles 292 347
Right of use asset/liabilities 26 12
Other 18 2
Total deferred tax assets 64,730 61,073
Deferred tax liabilities:    
Depreciation (763) (287)
Total deferred tax liabilities (763) (287)
Less valuation allowance (63,967) (60,786)
Net deferred tax liability